Effect of adoptive immunotherapy with CIK cells combined with interleukin-2 on immunologic function and life qualities of patients with non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2015.02.003
- VernacularTitle:CIK细胞联合白细胞介素-2对非小细胞肺癌患者免疫功能及生命质量的影响
- Author:
Ming XUE
;
Mingkun GUO
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung;
Immunotherapy;
Cytokine induced killer cells
- From:
Journal of International Oncology
2015;42(2):88-90
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the changes of immunologic functions and life qualities after the auto-cytokine induced killer (CIK) cells combined with interleukin-2 (IL-2) being transfused back to the patients with non-small cell lung cancer (NSCLC).Methods Thirty-eight NSCLC patients were enrolled,and 19 patients received not only chemotherapy and radiotherapy but also adoptive immunotherapy with CIK cells combined with IL-2 compared with the other 19 patients who only accepted radiotherapy and chemotherapy.The changes of immunologic functions and life qualities after the CIK cells combined with IL-2 being transfused back to the patients with NSCLC were observed.Immune targets of the treatment group and control group,such as peripheral blood CD3 +,CD4 +,CD8 + T cell percentage,ratio of CD4 +/CD8 + and Th1/Th2,were observed at the end and after 3 month of the radiation and chemotherapy.Results Both of the two groups were neither having obvious adverse reactions.After CIK cells combined with IL-2 treatment,the life qualities of patients improved,such as 18 cases of mental improvement,15 cases of appetite improvement,12 cases of sleep improvement,and 3 cases of fatigue symptoms improvement.The percentage of CD3 +,CD4 + cells in the treatment group increased [(66.39 ± 9.22) ％ vs (42.98 ± 7.23) ％,t =5.45,P =0.00 ; (32.27 ± 3.75) ％ vs (26.38 ±2.51)％,t =5.73,P =0.00],the percentage of CD8 + cells declined [(17.51 ± 1.85)％ vs (20.90 ± 2.31) ％,t =5.21,P =0.00],the rate of CD4 +/CD8 + increased and the rate of Th1/Th2 obversed [(1.86±0.32) vs (1.27±0.19),t=7.13,P=0.00;(1.15±0.48) vs (0.91 ±0.30),t=2.42,P=0.02].There were significant differences between the two groups.Conclusion Adoptive immunotherapy with CIK cells combined with IL-2 is safe in clinical,which can improve the immunologic functions and life qualities of the patients with NSCLC.
